Science
Healthcare
Pharmaceutical
Insurance
Resources
About
Contact

ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders

Homepage >> Press Releases >> ViewMind announces developer agreement with HP to help revolutionize the diagnosis and treatment of cognitive disorders

Click to read the Press Release

Related Posts

Our paper has been published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. Mario A Parra MD PhD, Juan Granada MD, gerardo fernandez PhD, et al. (2022). In a 40-month prospective study, ViewMind showed:

Highlights: • A biomarker to 'prospectively' predict Alzheimer's Disease with high accuracy. PPV 94% and NPV 100% • Ability to very accurately differentiate cognitive decline…

Neurocognitive disease management leader, ViewMind Inc., announces the opening of ViewMind Labs.

ViewMind is excited to announce the opening of ViewMind Labs at one of the most highly regarded centers of excellence globally for research and clinical…

ViewMind Inc. announces the appointment of Denise Kelly as Vice President Sales & Business Development

Science
Pharmaceutical
Healthcare
Insurance
Resources
About
Contact

Terms and conditions

© Copyright Viewmind 2018 - 2023 | All rights reserved